Cited by 2,833Cancer Genomics and DiagnosticsChromatin Remodeling and CancerGenomics and Rare Diseases

The Genomic Landscapes of Human Breast and Colorectal Cancers

Wood, Laura D., Parsons, D. Williams, Jones, Siân, Lin, Jimmy, Sjöblom, Tobias, Leary, Rebecca J., Shen, Dong, Boca, Simina M. +34 more·2007·Science

Abstract

Human cancer is caused by the accumulation of mutations in oncogenes and tumor suppressor genes. To catalog the genetic changes that occur during tumorigenesis, we isolated DNA from 11 breast and 11 colorectal tumors and determined the sequences of the genes in the Reference Sequence database in these samples. Based on analysis of exons representing 20,857 transcripts from 18,191 genes, we conclude that the genomic landscapes of breast and colorectal cancers are composed of a handful of commonly mutated gene “mountains” and a much larger number of gene “hills” that are mutated at low frequency. We describe statistical and bioinformatic tools that may help identify mutations with a role in tumorigenesis. These results have implications for understanding the nature and heterogeneity of human cancers and for using personal genomics for tumor diagnosis and therapy.

Integrity signals

Registry

Crossref · 10.1126/science.1145720

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The discovery of rare independent somatic mutations within and across genes contributing to tumorigenesis may parallel the functional effects of inherited variants contributing to congenital disease.

    “Second, the discovery of rare independent somatic mutations within and across genes contributing to tumorigenesis may parallel the functional effects of inherited variants contributing to congenital disease.11, 16, 17”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., Silliman, N., Szabo, S., Dezso, Z., Ustyanksky, V., Nikolskaya, T., Nikolsky, Y., Karchin, R., Wilson, P. A., Kaminker, J. S., Zhang, Z., Croshaw, R., Willis, J., Dawson, D., Shipitsin, M., Willson, J. K. V., Sukumar, S., Polyak, K., Park, B. H., Pethiyagoda, C. L., Pant, P. V. K., Ballinger, D. G., Sparks, A. B., Hartigan, J., Smith, D. R., Suh, E., Papadopoulos, N., Buckhaults, P., Markowitz, S. D., Parmigiani, G., Kinzler, K. W., Velculescu, V. E., & Vogelstein, B.
Affiliations
  • Howard Hughes Medical Institute (US)
  • The Ludwig Center for Cancer Genetics and Therapeutics and The Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.
Corresponding author
  • Wood, Laura D.
  • Parsons, D. Williams
  • Lin, Jimmy
  • Barber, Thomas
  • Sparks, Andrew B.
  • Parmigiani, Giovanni
  • Kinzler, Kenneth W.
  • Velculescu, Victor E.
  • Vogelstein, Bert
Venue
Science
Published
2007-11-16
Volume
318
Issue
5853
Pages
1108-1113
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4238448376
Cited by
2,833
References
31
Citations by year
2026: 26 · 2025: 44 · 2024: 61 · 2023: 100 · 2022: 70 · 2021: 89 · 2020: 98 · 2019: 98 · 2018: 119 · 2017: 141 · 2016: 154 · 2015: 179 · 2014: 198 · 2013: 237 · 2012: 243
FWCI
81.15
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca121113-15, 1r43gm070219-01a2)
  • National Cancer Institute (CA109274, CA 57345, P-30 CA43703, CA-121113, CA43460, CA112828, P50CA062924, P30CA043703, CA 62924)
  • National Institute of General Medical Sciences (T32GM007309, GM07309, GM070219)
  • National Center for Research Resources (RR017698, P20RR017698)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
breast cancer, colorectal cancer, somatic mutations, tumor suppressor, oncogenes, carcinogenesis, mutation frequency, tumor heterogeneity, personal genomics, tumor diagnosis, cancer therapy
MeSH terms
Animals, Breast Neoplasms, Cell Line, Chromosome Mapping, DNA, Neoplasm, Humans, Mutation, Neoplasm Proteins, Colorectal Neoplasms, Genome, Human, Sequence Analysis, DNA, Computational Biology, Databases, Genetic, Mice, Genes, Neoplasm, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review